Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05691972
NA

Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

Sponsor: Galderma R&D

View on ClinicalTrials.gov

Summary

This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.

Official title: A Randomized, No-treatment-controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing

Key Details

Gender

All

Age Range

22 Years - Any

Study Type

INTERVENTIONAL

Enrollment

225

Start Date

2023-03-14

Completion Date

2024-12-11

Last Updated

2026-05-22

Healthy Volunteers

No

Interventions

DEVICE

Restylane Contour

a sterile, biodegradable, transparent gel of nonanimal cross-linked HA (20 mg/mL) with the addition of lidocaine hydrochloride (3 mg/mL)

Locations (15)

Galderma Research Site

Phoenix, Arizona, United States

Galderma Research Site

Encino, California, United States

Galderma Research Site

Los Angeles, California, United States

Galderma Research Site

Redondo Beach, California, United States

Galderma Research Site

Solana Beach, California, United States

Galderma Research Site

Vista, California, United States

Galderma Research Site

Washington D.C., District of Columbia, United States

Galderma Research Site

Adventura, Florida, United States

Galderma Research Site

Boynton Beach, Florida, United States

Galderma Research Site

Coral Gables, Florida, United States

Galderma Research Site

New Orleans, Louisiana, United States

Galderma Research Site

New York, New York, United States

Galderma Research Site

Chapel Hill, North Carolina, United States

Galderma Research Site

Wilmington, North Carolina, United States

Galderma Research Site

Nashville, Tennessee, United States